HOME >> BIOLOGY >> NEWS
ESC Congress 2005 to utilise studies, sessions and sunshine to shed light on women and CVD

Sophia Antipolis, France, 21 June 2005: With the aim of better understanding and addressing women and cardiovascular disease (CVD), the European Society of Cardiology (ESC) has made women and CVD the focus of its next major annual event, the ESC Congress, which will take place in Stockholm, 3 7 September 2005.

The ESC Congress will highlight women and CVD by revealing results from the ESC Policy Conference and the ESC Euro Heart Survey during specific sessions at the Congress. The ESC also will provide information with regard to women and CVD during a two-day outdoor public event that will run alongside the ESC Congress, entitled 'For Your Heart's Sake,' 2 3 September 2005 in central Stockholm.

In preparation for the ESC Congress' focus, the ESC is convening a Policy Conference on 'CVD in Women' on 23 24 June 2005, which will bring together approximately 60 cardiologists and experts from the 49 ESC member countries to review and discuss medical literature on CVD in women. The group will evaluate the gap between scientific data and the perception about the role of CVD risk factors in women's health. Strategies will be discussed to promote research in the field of CVD in women and to educate both cardiologists and their patients. The results of this conference will be released during the ESC Congress 2005, and also through an article to be published in the European Heart Journal, an official journal of the ESC.

The ESC Congress' selection of sessions on women and CVD will include release of the Euro Heart Survey database analyses with incidence and treatment trends of women with CVD across Europe. Analyses of the Euro Heart Survey databases are expected to greatly contribute to an increased understanding and treatment of women and CVD through insight into manifestation, treatment and co-morbidity patterns in women compared to men.

There will also be a special focus on women and CVD, including specific information on risk factor reduc
'"/>

Contact: Gina Dellios
gdellios@escardio.org
33-492-948-627
European Society of Cardiology
21-Jun-2005


Page: 1 2 3

Related biology news :

1. AAAS analysis finds Congress would add billions to FY 2008 R&D investment
2. 2nd International EuroFIR Congress
3. Prize winners announced at ISNs World Congress of Nephrology
4. Nanotechnologys past, present and future: A Congressional perspective
5. Press registration -- World Congress of Nephrology, April 21-25, 2007, Rio de Janeiro, Brazil
6. Minister Lunn to speak at 10th National Forest Congress
7. Conservationist and actor Harrison Ford honored by Congressional Foundation
8. Q&A with Jeffrey Sachs on July 10 at Soils Congress
9. 18th World Congress of Soil Science
10. PITTs McGowan Institute for Regenerative Medicine presenting new research at World Congress
11. International Society of Nephrologys World Congress of Nephrology 2007

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... June 9, 2016  Perkotek an innovation leader in attendance control systems is proud ... work hours, for employers to make sure the right employees are actually signing in, ... ... ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
(Date:12/8/2016)... 8, 2016   Biocept, Inc . (NASDAQ: ... of clinically actionable liquid biopsy tests to improve ... data featuring its Target Selector™ Circulating Tumor Cell ... the detection of actionable biomarkers in patients with ... by Sara Cannon Research Institute (SCRI), the research ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... concluded that “in the setting of previously treated, advanced pancreatic cancer, liquid biopsies ... the optimal patient population and timing of blood sampling may improve the value ...
(Date:12/7/2016)... Neogen Corporation (NASDAQ: NEOG ) ... as its chief science officer — a new ... at Neogen effective Jan. 1. Kephart has ... unit of Thermo Fisher Scientific, as well as animal ... extensive industry experience also includes the management of a ...
Breaking Biology Technology:
Cached News: